These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 15587934)

  • 21. Ratio of pro-B-type natriuretic peptide (BNP) to total BNP is decreased in mild, but not severe, acute decompensated heart failure patients: A novel compensatory mechanism for acute heart failure.
    Takahama H; Takashio S; Nishikimi T; Hayashi T; Nagai-Okatani C; Nakagawa Y; Amaki M; Ohara T; Hasegawa T; Sugano Y; Kanzaki H; Yasuda S; Kangawa K; Minamino N; Anzai T
    Int J Cardiol; 2018 May; 258():165-171. PubMed ID: 29544926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BNP: pathophysiological and potential therapeutic roles in acute congestive heart failure.
    Grantham JA; Borgeson DD; Burnett JC
    Am J Physiol; 1997 Apr; 272(4 Pt 2):R1077-83. PubMed ID: 9140004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
    Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
    Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term cardiac pro-B-type natriuretic peptide gene delivery prevents the development of hypertensive heart disease in spontaneously hypertensive rats.
    Cataliotti A; Tonne JM; Bellavia D; Martin FL; Oehler EA; Harders GE; Campbell JM; Peng KW; Russell SJ; Malatino LS; Burnett JC; Ikeda Y
    Circulation; 2011 Mar; 123(12):1297-305. PubMed ID: 21403100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B-type natriuretic peptide infusions in acute myocardial infarction.
    Hillock RJ; Frampton CM; Yandle TG; Troughton RW; Lainchbury JG; Richards AM
    Heart; 2008 May; 94(5):617-22. PubMed ID: 17639095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic actions of a new synthetic vasoactive and natriuretic peptide, dendroaspis natriuretic peptide, in experimental severe congestive heart failure.
    Lisy O; Lainchbury JG; Leskinen H; Burnett JC
    Hypertension; 2001 Apr; 37(4):1089-94. PubMed ID: 11304508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vasodilatory effects of B-type natriuretic peptide are impaired in patients with chronic heart failure.
    Nakamura M; Arakawa N; Yoshida H; Makita S; Niinuma H; Hiramori K
    Am Heart J; 1998 Mar; 135(3):414-20. PubMed ID: 9506326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment with darusentan over 21 days improved cGMP generation in patients with chronic heart failure.
    Philipp S; Monti J; Pagel I; Langenickel T; Notter T; Ruschitzka F; Lüscher T; Dietz R; Willenbrock R
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():249S-253S. PubMed ID: 12193097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure.
    Yoshimura M; Yasue H; Tanaka H; Kikuta K; Sumida H; Kato H; Jougasaki M; Nakao K
    Br Heart J; 1994 Dec; 72(6):528-33. PubMed ID: 7857734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A sandwich ELISA for assessment of pharmacokinetics of HSA-(BNP)2 fusion protein in mouse plasma.
    Ding YD; Lei JY; Chen Y; Jin J
    J Pharm Biomed Anal; 2010 Feb; 51(3):658-63. PubMed ID: 19836183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined Assessment of Relaxin and B-Type Natriuretic Peptide Improves Diagnostic Value in Patients With Congestive Heart Failure.
    Han L; Luo J; Bai S; Jia Y; Chen X; Zhao Y; Chen L; Zhu X; Li Y; Jiang Y; Li X; Yang M; Li D; Teng X; Qi Y
    Am J Med Sci; 2017 Nov; 354(5):480-485. PubMed ID: 29173360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potentiation of brain natriuretic peptides by SQ 28,603, an inhibitor of neutral endopeptidase 3.4.24.11, in monkeys and rats.
    Seymour AA; Asaad MM; Abboa-Offei BE; Rovnyak PL; Fennell S; Rogers WL
    J Pharmacol Exp Ther; 1992 Jul; 262(1):60-70. PubMed ID: 1385630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atrial natriuretic factor and brain natriuretic peptide gene expression in the spontaneous hypertensive rat during postnatal development.
    Kuroski de Bold ML
    Am J Hypertens; 1998 Aug; 11(8 Pt 1):1006-18. PubMed ID: 9715795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Β-adrenergic blockade combined with subcutaneous B-type natriuretic peptide: a promising approach to reduce ventricular arrhythmia in heart failure?
    Thireau J; Karam S; Roberge S; Roussel J; Aimond F; Cassan C; Gac A; Babuty D; Le Guennec JY; Lacampagne A; Fauconnier J; Richard S
    Heart; 2014 Jun; 100(11):833-41. PubMed ID: 24667281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B-type natriuretic peptide in heart failure.
    Moe GW
    Curr Opin Cardiol; 2006 May; 21(3):208-14. PubMed ID: 16601459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biomarker responses during and after treatment with nesiritide infusion in patients with decompensated chronic heart failure.
    Miller WL; Hartman KA; Burritt MF; Borgeson DD; Burnett JC; Jaffe AS
    Clin Chem; 2005 Mar; 51(3):569-77. PubMed ID: 15615816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study.
    Cheng V; Kazanagra R; Garcia A; Lenert L; Krishnaswamy P; Gardetto N; Clopton P; Maisel A
    J Am Coll Cardiol; 2001 Feb; 37(2):386-91. PubMed ID: 11216951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure.
    Tsutamoto T; Wada A; Maeda K; Mabuchi N; Hayashi M; Tsutsui T; Ohnishi M; Sawaki M; Fujii M; Matsumoto T; Kinoshita M
    J Am Coll Cardiol; 2000 Mar; 35(3):714-21. PubMed ID: 10716475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [BNP-guided therapy optimizes the timing of discharge and the medium term risk stratification in patients admitted for congestive heart failure].
    Valle R; Aspromonte N; Carbonieri E; De Michele G; Di Tano G; Giovinazzo P; Cioè R; Di Giacomo T; Milani L; Noventa F; Chiatto M
    Monaldi Arch Chest Dis; 2007 Sep; 68(3):154-64. PubMed ID: 18361212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma concentrations of atrial and brain natriuretic peptides and cyclic guanosine monophosphate in response to dobutamine infusion in patients with surgically repaired tetralogy of fallot.
    Hayabuchi Y; Matsuoka S; Kuroda Y
    Pediatr Cardiol; 1999; 20(5):343-50. PubMed ID: 10441688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.